USANA Health Sciences Inc (USNA) stock
USNANYSEMedicinal Chemicals & Botanical ProductsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3058% below fair value
$13.57+0.03 (+0.22%)
Close on Nov 17, 2026Market cap $250.73MP/E –Yield –
USANA Health Sciences r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $10.69M, down 7.6% from the year before. Over ten years it grew 5.2% a year on average. The highest annual figure on record is $11.57M in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $10.69M | -7.6% |
| FY2024 | Dec 28, 2024 | $11.57M | +1.1% |
| FY2023 | Dec 30, 2023 | $11.45M | -1.0% |
| FY2022 | Dec 31, 2022 | $11.56M | +4.1% |
| FY2021 | Jan 1, 2022 | $11.11M | +4.5% |
| FY2020 | Jan 2, 2021 | $10.63M | +3.6% |
| FY2019 | Dec 28, 2019 | $10.26M | +0.2% |
| FY2018 | Dec 29, 2018 | $10.24M | +14.4% |
| FY2017 | Dec 30, 2017 | $8.95M | +1.2% |
| FY2016 | Dec 31, 2016 | $8.84M | +37.7% |
| FY2015 | Jan 2, 2016 | $6.42M | +25.2% |
| FY2014 | Jan 3, 2015 | $5.13M | +0.9% |
| FY2013 | Dec 28, 2013 | $5.08M | +9.0% |
| FY2012 | Dec 29, 2012 | $4.66M | +14.6% |
| FY2011 | Dec 31, 2011 | $4.07M | +6.0% |
| FY2010 | Jan 1, 2011 | $3.84M | – |
See a number that looks wrong?